Skip to main content
Terug
Watch Compare

IMMUCELL CORP /DE/

Datakwaliteit: 100%
ICCC
NASDAQ Manufacturing Chemicals
€ 7,08
▼ € 0,11 (-1,53%)
Marktkapitalisatie: 65,05 M
Prijs
€ 7,19
Marktkapitalisatie
65,05 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,32 — conservative balance sheet
Generating 1,22 M in free cash flow
Capital efficient — spends only 4,52% of revenue on capex
ROIC of 3,10% — low return on invested capital

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)4,34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-3,49%
Boven sectorgemiddelde (-54,44%)
ROIC3,10%
Net Margin-3,76%
Op. Margin5,97%

Veiligheid

Debt / Equity
0,32
Boven sectorgemiddelde (0,30)
Current Ratio4,21
Interest Coverage3,34

Waardering

PE (TTM)
-62,54
Onder sectorgemiddelde (-1,49)
P/B Ratio2,18
EV/EBITDA15,94
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -62,5 -1,5
P/B 2,2 1,6
ROE % -3,5 -54,4
Net Margin % -3,8 -41,5
Rev Growth 5Y % — 1,9
D/E 0,3 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42020 -€ 0,04 € 0,03 +175,0%
Q32020 -€ 0,08 -€ 0,04 +50,0%
Q22020 -€ 0,10 -€ 0,11 -10,0%
Q12020 N/A -€ 0,02 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 4,34% Revenue Growth (3Y) 25,79%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 27,64 M Net Income (TTM) -1,04 M
ROE -3,49% ROA -2,25%
Gross Margin 41,40% Operating Margin 5,97%
Net Margin -3,76% Free Cash Flow (TTM) 1,22 M
ROIC 3,10% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,32 Current Ratio 4,21
Interest Coverage 3,34 Asset Turnover 0,60
Working Capital 12,83 M Tangible Book Value 29,70 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -62,54 Forward P/E N/A
P/B Ratio 2,18 P/S Ratio 2,35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 15,94 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1,88%
Market Cap 65,05 M Enterprise Value 70,65 M
Per Share
EPS (Diluted TTM) -0,12 Revenue / Share 3,06
FCF / Share 0,14 OCF / Share 0,27
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4,52% FCF Conversion -117,77%
SBC-Adj. FCF 955.206 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 27,64 M 26,49 M 17,47 M — —
Net Income -1,04 M -2,16 M -5,77 M -2,49 M -78.292,0
EPS (Diluted) -0,12 -0,26 -0,75 -0,32 -0,01
Gross Profit 11,45 M 7,94 M 3,87 M 7,65 M 8,66 M
Operating Income 1,65 M -1,64 M -5,75 M -2,30 M 257.385,0
EBITDA — — — — —
R&D Expenses 3,04 M 3,90 M 4,39 M 4,49 M 4,17 M
SG&A Expenses — — — — —
D&A 2,78 M — — — —
Interest Expense 493.384,0 — 475.598,0 348.536,0 —
Income Tax 11.570,0 10.056,0 4.627,0 7.672,0 9.165,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 42,53 M 45,10 M 43,81 M 44,86 M 44,47 M
Total Liabilities 15,48 M 17,58 M 18,82 M 14,48 M 11,89 M
Shareholders' Equity 27,06 M 27,52 M 24,99 M 30,38 M 32,58 M
Total Debt 9,10 M — 10,43 M 10,23 M 812.207,0
Cash & Equivalents 3,81 M — 978.741,0 5,79 M 10,19 M
Current Assets 16,94 M 15,04 M — 13,99 M 16,26 M
Current Liabilities 3,98 M 4,41 M 4,20 M 3,07 M 2,53 M